Clinical Oncology Next Generation Sequencing Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact – both negative and positive – of COVID-19 on the clinical oncology next generation sequencing industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. This includes revised market numbers according to the effects of the coronavirus and the expected clinical oncology next generation sequencing market growth numbers 2021-2030.

View Complete Report:

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report-2020-30-covid-19-growth-and-change

The Clinical Oncology Next Generation Sequencing Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global clinical oncology next generation sequencing market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030. The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Clinical Oncology Next Generation Sequencing Global Market Report 2021 covers clinical oncology next generation sequencing market drivers, clinical oncology next generation sequencing market trends, clinical oncology next generation sequencing market growth rate, clinical oncology next generation sequencing market major players, player-adopted strategies in the market, and clinical oncology next generation sequencing market size.

The global clinical oncology next generation sequencing market is expected to grow from $0.44 billion in 2020 to $0.56 billion in 2021 at a compound annual growth rate (CAGR) of 27.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global clinical oncology NGS market is expected to reach $1.05 billion in 2025 at a CAGR of 17%.

Request For The Sample Now:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3344&type=smp

The report covers the clinical oncology next generation sequencing market segments-

1) By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing

2) By Application: Screening, Companion Diagnostics, Other Diagnostics

3) By End User: Hospital Laboratories, Clinical Research Organizations, Diagnostic laboratories

About The Business Research Company:

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.

Contact Information:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

Check out our Blog: http://blog.tbrc.info/